Article
Adaptation to ARF6-depletion in KRAS-driven PDAC is abolished by targeting TLR2
2023-12-02
Abstract excerpt
<h4>SUMMARY</h4> Metastasis is responsible for nearly 90% of all cancer-related deaths. Despite global efforts to prevent aggressive tumours, cancers such as pancreatic ductal adenocarcinoma (PDAC) are poorly diagnosed in the primary stage, resulting in lethal metastatic disease. RAS mutations are known to promote tumour spread, with mutant KRAS present in up to 90% of cases. Until recently, mutant KRAS remained...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b8998475-ee6d-5099-9053-f68968d2373a
- DOI
- 10.1101/2023.11.30.569405
